Snowball logo
logo
1783

Maxigen Biotech Inc

1783 TW
NT$40.40+NT$0.05  (0.12%)
Estimate
P/E
13.5
EPS
3
Beta
0.382
Growth
Revenue, YoY
5.84%
Net income, YoY
34.24%
About the company
Ticker
1783
ISIN
TW0001783009
Country
Taiwan
Sector (GICS)
Consumer Staples
Maxigen Biotech Inc. researches, develops, produces, and sells implantable medical devices in Taiwan, America, Europe, rest of Asia, and internationally. It operates through two segments, Biomedical Products and Consumer Products. The company provides biomedical materials, such as collagen and bone supplements; beauty and skincare products; and medical devices for ophthalmology, otolaryngology, dental, surgical, orthopedics, electronic instructions for use, and medical aesthetics, as well as engages in collagen purification activities. It also offers ophthalmic viscoelastic under the PreviscAid, ViscAid, and BiVisc brands; intra-articular injections under the ArtiBest and ArtiAid brands; synthetic bone grafts under the BestAid, GingivAid, FormaGraft, and Foramic brands; and dermal filler injections under the Formaderm brand. In addition, the company provides collagen based regenerative matrixes comprising HealiAid, a collagen wound dressing; NasoAid, an intranasal splint; and FormaAid, a collagen membrane. Maxigen Biotech Inc. was incorporated in 1998 and is headquartered in Taoyuan City, Taiwan.

Frequently asked questions

What sector does Maxigen Biotech Inc (1783) operate in?

Maxigen Biotech Inc belongs to the Consumer Staples sector and operates in the Medical Instruments & Supplies industry.

What is Maxigen Biotech Inc (1783) current stock price?

As of the latest data, Maxigen Biotech Inc stock price is NT$40.40, with a previous close of NT$40.35. Maxigen Biotech Inc gained NT$0.05 in the last trading session, representing a 0.12% increase.

What is Maxigen Biotech Inc (1783) current market capitalization?

Maxigen Biotech Inc market cap is approximately 3.62 billion.

What is Maxigen Biotech Inc (1783) Earnings Per Share (EPS)?

The trailing EPS is NT$3.00.

What is Maxigen Biotech Inc (1783) Price-to-Earnings (P/E) ratio?

Maxigen Biotech Inc current P/E ratio is 13.47.

What is Maxigen Biotech Inc (1783) EBITDA?

Maxigen Biotech Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 56.78 million.

Does Maxigen Biotech Inc (1783) pay dividends?

No. Maxigen Biotech Inc does not pay a dividend.

What is Maxigen Biotech Inc (1783) beta (volatility) score?

Maxigen Biotech Inc has a beta of 0.382, indicating lower volatility than the overall market.